The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

The Food and Drug Administration (FDA) has approved Arbli ™, an oral suspension formulation of losartan potassium ... adults and children greater than 6 years old; for the reduction of the ...

Scienture shares originally traded higher on Tuesday but have since reversed and began trading lower after the company ...

Losartan is a prescription drug. It comes as an oral tablet ... Child dosage (ages 6 to 17 years) The dosage is based on the child’s weight. The usual dosage is around 0.7 mg per kilogram ...

A Laurel man is facing his sixth DUI charge. Delaware State Police said that a trooper pulled over a pickup truck driven by ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers ...

Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...

HOLDINGS has completed a draw on its Equity Line of Credit to support the commercial launch of Arbli Oral Suspension, while ...

A Laurel man has been arrested spotted a pickup truck with an unsecured load of wood traveling slowing on Camp Road near ...